For insulin receptor (INSR), genetic mutations impair receptor function, disrupting insulin signaling and promoting insulin resistance, a key driver of NAFLD pathogenesis (Nobakht et al., 2020). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.